Gelteq Limited (NasdaqCM: GELS)
Health Care · Pharmaceuticals · AU
$0.52
-0.02% today · -61.1% 1Y
Gelteq Limited (NasdaqCM: GELS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.83M and employs 18 people.
Over the last twelve months the share price has lost 61.1%, trading between 0.39 and 2.01.
Tweenvest scores Gelteq Limited across four factors: quality 37/100, value 52/100. Its strongest factor is value.
GELS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.83M
- Revenue (TTM)
- $314.70K
- P/E
- —
- EPS
- -0.70
- Dividend yield
- —
- Beta (5Y)
- -0.39
- 52-week high
- $2.01
- 52-week low
- $0.39
- Avg volume (3M)
- —
- Shares outstanding
- 11.18M
- Employees
- 18
- Next earnings
- —
About Gelteq Limited
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
- ISIN
- AU0000218109
- Founded
- 2017
- Listed since
- Oct 29, 2024
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| InnoCan Pharma CorporationCNSX: INNO | $5.99M | CA$1.80 | -18.18% |
| Cardiac Biotech Solutions Inc.OTCPK: CBSC | $5.97M | $0.04 | +11.29% |
| Avant Brands Inc.TSX: AVNT | $5.93M | CA$0.55 | +7.84% |
| Sonoma Pharmaceuticals, Inc.NasdaqCM: SNOA | $5.89M | $1.23 | +6.03% |
| Firebrick Pharma LimitedASX: FRE | $5.81M | AU$0.03 | +3.57% |
| Panacea Life Sciences Holdings, Inc.OTCPK: PLSH | $5.78M | $0.09 | +6.25% |
| Invex Therapeutics LtdASX: IXC | $5.77M | AU$0.11 | -4.35% |
| ECS Botanics Holdings LtdASX: ECS | $5.59M | AU$0.01 | -9.09% |
Figures last refreshed Oct 11, 2026.